Latest filing published 15 Jun 2023 for Acutus Medical, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Niamh Louise Pellegrini is a declared insider at 2 companies (chief executive); the most frequent names are Nevro Corp and Acutus Medical, Inc. In total, 11 filings cover trades dated from 6 August 2021 to 15 June 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 15 June 2023, reports a share grant in Acutus Medical, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations